Avanzanite Bioscience is a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases. The company aims to solve Europe's rare-disease medicines access gap by integrating commercial excellence, scientific expertise, and deep functional capability across market access, pricing, and reimbursement.
Leadership & Board
Current Number of Employees93
Current LinkedIn Followers5,787
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$32M
Total Amount Raised$32M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$32M
Latest Funding Amount$32M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Avanzanite Bioscience had 93 employees as of September 7, 2026. The number of employees increased by 3 (3.33%) week-over-week.
93Latest Employee Count
3(3.33%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Avanzanite Bioscience had 5,787 followers as of September 7, 2026. The number of followers increased by 46 (0.80%) week-over-week.
5,787Latest Followers Count
46(0.80%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.